Apogee Therapeutics, Inc. (APGE) is listed on NASDAQ in Biotech Stocks. It is $134.97, +0.00%, with a $10.2B market cap. RSI is 69.6, near overbought. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 69.6 Near Overbought
Market Cap $10.2B
Volume 564.7K
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-160.0M
EPS $-2.20
P/E Ratio -61.3x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Dambkowski Carl | Chief Medical Officer | Sell | 5,500 | $134.17 | $737,935 | 2026 Aug 5 |
| Henderson Michael Thomas | Chief Executive Officer | Sell | 20,000 | $133.63 | $2.7M | 2026 Jul 8 |
| Dambkowski Carl | Chief Medical Officer | Sell | 5,500 | $132.74 | $730,070 | 2026 Jul 1 |
| Dambkowski Carl | Chief Medical Officer | Sell | 26,400 | $132.60 | $3.5M | 2026 Jun 22 |
| Henderson Michael Thomas | Chief Executive Officer | Sell | 80,000 | $132.54 | $10.6M | 2026 Jun 22 |
| Henderson Michael Thomas | Chief Executive Officer | Sell | 20,000 | $83.38 | $1.7M | 2026 Jun 10 |
| Dambkowski Carl | Chief Medical Officer | Sell | 5,500 | $78.71 | $432,905 | 2026 Jun 3 |
| Henderson Michael Thomas | Chief Executive Officer | Sell | 20,000 | $82.09 | $1.6M | 2026 May 13 |
| Dambkowski Carl | Chief Medical Officer | Sell | 5,500 | $84.14 | $462,784 | 2026 May 6 |
| Henderson Jane | Chief Financial Officer | Sell | 2,000 | $82.04 | $164,080 | 2026 May 1 |
| Henderson Jane | Chief Financial Officer | Sell | 2,000 | $90.00 | $180,000 | 2026 Apr 16 |
| Henderson Michael Thomas | Chief Executive Officer | Sell | 20,000 | $82.58 | $1.7M | 2026 Apr 8 |
| Dambkowski Carl | Chief Medical Officer | Sell | 5,500 | $84.84 | $466,619 | 2026 Apr 1 |
| Henderson Jane | Chief Financial Officer | Sell | 2,000 | $85.01 | $170,020 | 2026 Apr 1 |
| Henderson Jane | Chief Financial Officer | Sell | 2,000 | $85.00 | $170,000 | 2026 Mar 25 |
| Henderson Michael Thomas | Chief Executive Officer | Sell | 20,000 | $74.78 | $1.5M | 2026 Mar 11 |
| Dambkowski Carl | Chief Medical Officer | Sell | 5,500 | $71.06 | $390,825 | 2026 Mar 4 |
| Henderson Jane | Chief Financial Officer | Sell | 2,000 | $70.22 | $140,431 | 2026 Mar 2 |
| Henderson Jane | Chief Financial Officer | Sell | 1,500 | $80.00 | $120,000 | 2025 Dec 19 |
| Henderson Michael Thomas | Chief Executive Officer | Sell | 20,000 | $75.38 | $1.5M | 2025 Dec 10 |
Other Biotech Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $137.93 | 63.6 | $55.1B |
| | $432.33 | 66.2 | $233.7B |
| | $145.64 | 60.3 | $180.6B |
| | $105.31 | 69.1 | $12.0B |
| | $102.12 | 51.7 | -- |
| | $72.36 | 58.5 | $11.3B |
| | $141.42 | 61.5 | $8.9B |
| | $153.99 | 40.2 | $15.7B |
Take APGE further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put APGE in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Apogee Therapeutics, Inc. next reports.
Set alerts on APGE
Get notified when Apogee Therapeutics, Inc. hits your price targets or technical conditions are met.
Get Started Free